Doctor profile · Federal record

Dr. Atul Singhal, M.D. FACR

Rheumatology Physician (CMS: Rheumatology) · Mesquite, TX

  • NPI 1346256773
  • Accepts Medicare
  • MIPS 0.0 / 100 · 2023
  • 40 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1600 Republic Pkwy, Suite 200
Mesquite, TX 751506918
(972) 288-2600
fax (972) 288-8886

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
April 21, 2017
Year of graduation
1986 — 40 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Texas #J8374
Medicaid
TX #144682501

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1346256773. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
64,440
Distinct HCPCS
9
Medicare allowed
$360,198
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 63,600 18 $5
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 262 18 $72
96413 Administration of chemotherapy into vein, 1 hour or less 184 34 $132
96415 Administration of chemotherapy into vein, each additional hour 104 18 $28
99214 Established patient office or other outpatient visit, 30-39 minutes 83 49 $129
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 73 13 $1
99213 Established patient office or other outpatient visit, 20-29 minutes 54 37 $90
96372 Injection of drug or substance under skin or into muscle 49 15 $14
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 31 19 $66

In context: peer comparison

Among 2 peers in Mesquite Rheumatology Physician, average services per provider: 6,007. This provider delivers 11× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,661
Transactions
146
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Ucb Sa 7 $1,158.77
Abbvie INC. 34 $575.93
Novartis Pharmaceuticals Corporation 29 $499.56
Amgen INC. 17 $256.09
Ucb, INC. 12 $223.22
GlaxoSmithKline, LLC. 10 $193.49
Janssen Scientific Affairs, LLC 1 $142.35
AstraZeneca Pharmaceuticals Lp 6 $121.78
Celgene Corporation 3 $104.09
Janssen Biotech, INC. 7 $87.71
Radius Health, INC. 4 $80.07
Pfizer INC. 4 $65.88
Organon LLC 8 $64.62
Fresenius Kabi USA, LLC 3 $49.73
Octapharma USA, INC. 1 $23.18

By nature of payment

Food and Beverage
$2,722
Travel and Lodging
$934
Education
$6

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,172
Patients
288
Total drug cost
$275,805
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 202 59 $8,631
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 185 31 $8,381
Prednisone Generic 175 49 $1,521
Tramadol Hcl Generic 116 20 $1,511
Meloxicam Generic 73 15 $298
Cyclobenzaprine Hcl Generic 65 17 $461
Leflunomide Generic 59 17 $3,569
Hydroxychloroquine Sulfate Generic 52 18 $3,810
Sulfasalazine Generic 40 12 $1,564
Alprazolam Generic 38 0 $158

Frequently asked questions

Auto-generated from federal data
What is Dr. Atul Singhal's medical specialty?
Dr. Atul Singhal practices Rheumatology Physician in Mesquite, TX.
Where does Dr. Atul Singhal practice?
Dr. Atul Singhal practices at 1600 Republic Pkwy, Mesquite, TX 751506918. Office phone: 9722882600.
What is Dr. Atul Singhal's NPI?
Dr. Atul Singhal's National Provider Identifier (NPI) is 1346256773, issued by NPPES.
Does Dr. Atul Singhal accept Medicare assignment?
Yes. Dr. Atul Singhal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Atul Singhal commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS 96401); Administration of chemotherapy into vein (HCPCS 96413). Source: CMS Medicare Physician & Other Practitioners file.